Literature DB >> 19894403

Prevalence, morphology, and prognosis of human papillomavirus in tonsillar cancer.

Adam Luginbuhl1, Melinda Sanders, Jeffrey D Spiro.   

Abstract

OBJECTIVES: We sought to identify the prevalence of human papillomavirus (HPV) in tonsillar squamous cell carcinoma, and to examine the relationship of HPV to prognosis and tumor morphology.
METHODS: We performed in situ hybridization for HPV and retrospective clinical outcome analysis.
RESULTS: Of the 48 patients with tonsillar carcinoma, in situ hybridization identified 35% as HPV-positive tumors. Age-matched controls had no evidence of HPV. There was no significant difference between HPV-positive and HPV-negative patients regarding age (p = 0.34), tobacco consumption (p = 0.59), alcohol consumption (p = 0.91), or treatment method (p = 0.39). Forty-four patients were eligible for outcome analysis. The overall rate of recurrence in this population was 25%, and the disease-specific survival rate was 84%. There was no significant difference between the two groups either in the incidence of recurrence (p = 0.14) or in the disease-specific survival rate (p = 0.19). HPV-associated tumors developed from the tonsillar crypts significantly more frequently than did HPV-negative tumors (p = 0.01).
CONCLUSIONS: As previously described, HPV is significantly associated with squamous cell carcinoma of the tonsil; however, HPV status in our series did not correlate with clinical outcome. Morphologically, we found that HPV-positive tumors had their origin in the tonsillar crypts, whereas HPV-negative tumors arose from the surface epithelium.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19894403     DOI: 10.1177/000348940911801010

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  7 in total

1.  Prevalence of tonsillar human papillomavirus infections in Denmark.

Authors:  M Rusan; T E Klug; J J Henriksen; J H Bonde; K Fuursted; T Ovesen
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-08-12       Impact factor: 2.503

2.  Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma.

Authors:  Takatsugu Mizumachi; Satoshi Kano; Tomohiro Sakashita; Hiromitsu Hatakeyama; Seigo Suzuki; Akihiro Homma; Nobuhiko Oridate; Satoshi Fukuda
Journal:  Int J Clin Oncol       Date:  2012-08-31       Impact factor: 3.402

3.  The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases.

Authors:  Jan Laco; Hana Vosmikova; Vendula Novakova; Petr Celakovsky; Helena Dolezalova; Lubos Tucek; Jana Nekvindova; Milan Vosmik; Eva Cermakova; Ales Ryska
Journal:  Virchows Arch       Date:  2011-01-11       Impact factor: 4.064

4.  Discrimination of 'driver' and 'passenger' HPV in tonsillar carcinomas by the polymerase chain reaction, chromogenic in situ hybridization, and p16(INK4a) immunohistochemistry.

Authors:  Mark Francis Evans; Alisa Matthews; Dina Kandil; Christine Stewart-Crawford Adamson; Winifred Elizabeth Trotman; Kumarasen Cooper
Journal:  Head Neck Pathol       Date:  2011-07-24

5.  Relationship Between p16 Expression and Prognosis in Patients with Oropharyngeal Cancer Undergoing Surgery.

Authors:  Kota Kida; Tomonori Terada; Nobuhiro Uwa; Yoshihiko Omori; Takashi Fujii; Yasuhiko Tomita; Kenzo Tsuzuki; Hiroki Nishikawa; Masafumi Sakagami
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

Review 6.  It Takes Two to Tango: A Review of Oncogenic Virus and Host Microbiome Associated Inflammation in Head and Neck Cancer.

Authors:  Mallory G McKeon; Jean-Nicolas Gallant; Young J Kim; Suman R Das
Journal:  Cancers (Basel)       Date:  2022-06-25       Impact factor: 6.575

7.  Chromogenic in situ hybridization and p16/Ki67 dual staining on formalin-fixed paraffin-embedded cervical specimens: correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications.

Authors:  Roberta Zappacosta; Antonella Colasante; Patrizia Viola; Tommaso D'Antuono; Giuseppe Lattanzio; Serena Capanna; Daniela Maria Pia Gatta; Sandra Rosini
Journal:  Biomed Res Int       Date:  2013-11-24       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.